CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

NUVAXOVID

RegulatoryapprovedNUVAXOVIDPositive
AI Analysis

Summary

NUVAXOVID is approved for active immunization against COVID-19 in individuals aged 12 years and older. The approval includes specific age-stratified indications for usage.

Outcome Details

NUVAXOVID approved for use in individuals 65 years of age and older, and 12 years through 64 years of age

Importance:3/10
Sentiment:
0.50
COVID-19vaccineregulatory approvalimmunization
Related Companies

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on September 14, 2026 8:51 PM

Read Original